Immune cell topography predicts response to PD-1 blockade in cutaneous T cell lymphoma
Darci Phillips, Magdalena Matusiak, Belén Rivero Gutierrez, Salil S. Bhate, Graham L. Barlow, Sizun Jiang, Janos Demeter, Kimberly S. Smythe, Robert H. Pierce, Steven P. Fling, Nirasha Ramchurren, Martin A. Cheever, Yury Goltsev, Robert B. West, Michael S. Khodadoust, Youn H. Kim, Christian M. Schürch, Garry P. Nolan
doi: https://doi.org/10.1101/2020.12.06.20244913
Darci Phillips
1Department of Microbiology & Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA
2Department of Dermatology, Stanford University School of Medicine, Stanford, CA 94305, USA
3Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA
Magdalena Matusiak
3Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA
Belén Rivero Gutierrez
3Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA
Salil S. Bhate
1Department of Microbiology & Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA
3Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA
4Department of Bioengineering, Stanford University Schools of Engineering and Medicine, Stanford, CA 94305, USA
Graham L. Barlow
1Department of Microbiology & Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA
3Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA
Sizun Jiang
1Department of Microbiology & Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA
3Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA
Janos Demeter
1Department of Microbiology & Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA
Kimberly S. Smythe
5Cancer Immunotherapy Trials Network, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
Robert H. Pierce
5Cancer Immunotherapy Trials Network, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
Steven P. Fling
5Cancer Immunotherapy Trials Network, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
Nirasha Ramchurren
5Cancer Immunotherapy Trials Network, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
Martin A. Cheever
5Cancer Immunotherapy Trials Network, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
Yury Goltsev
1Department of Microbiology & Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA
3Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA
Robert B. West
3Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA
Michael S. Khodadoust
6Division of Oncology, Stanford University School of Medicine, Stanford, CA 94305, USA
Youn H. Kim
2Department of Dermatology, Stanford University School of Medicine, Stanford, CA 94305, USA
6Division of Oncology, Stanford University School of Medicine, Stanford, CA 94305, USA
Christian M. Schürch
1Department of Microbiology & Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA
3Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA
Garry P. Nolan
1Department of Microbiology & Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA
3Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA
Data Availability
All data generated or analyzed in this study are included in this Medrxiv article or available upon reasonable request.
Posted December 08, 2020.
Immune cell topography predicts response to PD-1 blockade in cutaneous T cell lymphoma
Darci Phillips, Magdalena Matusiak, Belén Rivero Gutierrez, Salil S. Bhate, Graham L. Barlow, Sizun Jiang, Janos Demeter, Kimberly S. Smythe, Robert H. Pierce, Steven P. Fling, Nirasha Ramchurren, Martin A. Cheever, Yury Goltsev, Robert B. West, Michael S. Khodadoust, Youn H. Kim, Christian M. Schürch, Garry P. Nolan
medRxiv 2020.12.06.20244913; doi: https://doi.org/10.1101/2020.12.06.20244913
Immune cell topography predicts response to PD-1 blockade in cutaneous T cell lymphoma
Darci Phillips, Magdalena Matusiak, Belén Rivero Gutierrez, Salil S. Bhate, Graham L. Barlow, Sizun Jiang, Janos Demeter, Kimberly S. Smythe, Robert H. Pierce, Steven P. Fling, Nirasha Ramchurren, Martin A. Cheever, Yury Goltsev, Robert B. West, Michael S. Khodadoust, Youn H. Kim, Christian M. Schürch, Garry P. Nolan
medRxiv 2020.12.06.20244913; doi: https://doi.org/10.1101/2020.12.06.20244913
Subject Area
Subject Areas
- Addiction Medicine (354)
- Allergy and Immunology (678)
- Anesthesia (182)
- Cardiovascular Medicine (2678)
- Dermatology (227)
- Emergency Medicine (404)
- Epidemiology (12310)
- Forensic Medicine (10)
- Gastroenterology (769)
- Genetic and Genomic Medicine (4156)
- Geriatric Medicine (390)
- Health Economics (685)
- Health Informatics (2693)
- Health Policy (1010)
- Hematology (365)
- HIV/AIDS (861)
- Medical Education (401)
- Medical Ethics (110)
- Nephrology (444)
- Neurology (3931)
- Nursing (212)
- Nutrition (584)
- Oncology (2070)
- Ophthalmology (595)
- Orthopedics (243)
- Otolaryngology (307)
- Pain Medicine (253)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1130)
- Primary Care Research (461)
- Public and Global Health (6576)
- Radiology and Imaging (1420)
- Respiratory Medicine (876)
- Rheumatology (414)
- Sports Medicine (345)
- Surgery (455)
- Toxicology (54)
- Transplantation (189)
- Urology (169)